Market Research Logo

Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

Advaxis Inc (ADXS) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description- A detailed description of the company’s operations and business divisions.
  • Corporate strategy- Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis- A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history- Progression of key events associated with the company.
  • Major products and services- A list of major products, services and brands of the company.
  • Key competitors- A list of key competitors to the company.
  • Key employees- A list of the key executives of the company.
  • Executive biographies- A brief summary of the executives’ employment history.
  • Key operational heads- A list of personnel heading key departments/functions.
  • Important locations and subsidiaries- A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities- A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years- The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods- The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm) bacteria to stimulate cancer-fighting T cells directed against a cancer antigen, and lessen factors that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Under the Lm Technology platform, the company has four immunotherapy candidates in development, Axalimogene filolisbac (AXAL) in Human Papilloma Virus (HPV)-associated cancers; Neoantigen Therapy (ADXS-NEO); ADXS-PSA in prostate cancer; and ADXS-HER2 in HER2-expressing solid tumors. Advaxis is headquartered in Princeton, New Jersey, the US.

Advaxis Inc Key Recent Developments

Feb 06,2019: Advaxis presents an overview of its Lm platform and neoantigen-directed programs at the Immuno-Oncology 360° Conference
Jan 28,2019: Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360° Conference
Jan 10,2019: Advaxis reports fiscal year 2018 financial results and provides a business update
Nov 06,2018: Advaxis to Present Poster Entitled Natural Killer (NK) Cells Orchestrate the Antitumor Activities of Listeria monocytogenes (Lm)-Based Immunotherapy at Society for Immunotherapy of Cancer Annual Meeting
Nov 02,2018: Advaxis Provides Update on Clinical Pipeline

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Advaxis Inc - Key Facts
Advaxis Inc - Key Employees
Advaxis Inc - Key Employee Biographies
Advaxis Inc - Major Products and Services
Advaxis Inc - History
Advaxis Inc - Company Statement
Advaxis Inc - Locations And Subsidiaries
Head Office
Section 2- Company Analysis
Company Overview
Advaxis Inc - Business Description
Advaxis Inc - Corporate Strategy
Advaxis Inc - SWOT Analysis
SWOT Analysis - Overview
Advaxis Inc - Strengths
Advaxis Inc - Weaknesses
Advaxis Inc - Opportunities
Advaxis Inc - Threats
Advaxis Inc - Key Competitors
Section 3- Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4- Company’s Lifesciences Financial Deals and Alliances
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Advaxis Inc, Recent Deals Summary
Section 5- Company’s Recent Developments
Feb 06, 2019: Advaxis presents an overview of its Lm platform and neoantigen-directed programs at the Immuno-Oncology 360° Conference
Jan 28, 2019: Advaxis to Present an Overview of its Lm Platform and New Information on its Neoantigen-Directed Therapy Programs at the Immuno-Oncology 360 Conference
Jan 10, 2019: Advaxis reports fiscal year 2018 financial results and provides a business update
Sep 10, 2018: Advaxis reports fiscal 2018 third quarter financial results
Jul 10, 2018: Advaxis Provides Update on MAA Filing and ADXS-HOT Program
Jun 07, 2018: Advaxis Announces Prioritization of Product Portfolio and Reports Fiscal 2018 Second Quarter Financial Results
Jun 06, 2018: Advaxis Appoints Molly Henderson as Chief Financial Officer
May 22, 2018: COMECER AMERICA signs a new agreement for the production of an aseptic manufacturing system (isolator technology) for Advaxis
Apr 23, 2018: Advaxis Announces Executive Leadership Changes
Mar 12, 2018: Advaxis Announces Q1 Fiscal 2018 Financial Results
Section 6- Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Advaxis Inc, Key Facts
Advaxis Inc, Key Employees
Advaxis Inc, Key Employee Biographies
Advaxis Inc, Major Products and Services
Advaxis Inc, History
Advaxis Inc, Key Competitors
Advaxis Inc, Ratios based on current share price
Advaxis Inc, Annual Ratios
Advaxis Inc, Annual Ratios (Cont...1)
Advaxis Inc, Interim Ratios
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Advaxis Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Advaxis Inc, Performance Chart (2014 - 2018)
Advaxis Inc, Ratio Charts
Advaxis Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Advaxis Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report